- 1.
Cheung K, Hume P, Maxwell L. Delayed onset muscle soreness : treatment strategies and performance factors. Sports Med 2003; 33: 145–64. [PubMed][CrossRef]
- 2.
Paulsen G, Mikkelsen UR, Raastad T et al. Leucocytes, cytokines and satellite cells: what role do they play in muscle damage and regeneration following eccentric exercise? Exerc Immunol Rev 2012; 18: 42–97. [PubMed]
- 3.
Mizumura K, Taguchi T. Delayed onset muscle soreness: Involvement of neurotrophic factors. J Physiol Sci 2016; 66: 43–52. [PubMed][CrossRef]
- 4.
Lauritzen F, Paulsen G, Raastad T et al. Gross ultrastructural changes and necrotic fiber segments in elbow flexor muscles after maximal voluntary eccentric action in humans. J Appl Physiol (1985) 2009; 107: 1923–34. [PubMed][CrossRef]
- 5.
Proske U, Allen TJ. Damage to skeletal muscle from eccentric exercise. Exerc Sport Sci Rev 2005; 33: 98–104. [PubMed][CrossRef]
- 6.
Raastad T, Owe SG, Paulsen G et al. Changes in calpain activity, muscle structure, and function after eccentric exercise. Med Sci Sports Exerc 2010; 42: 86–95. [PubMed][CrossRef]
- 7.
Paulsen G, Egner IM, Drange M et al. A COX-2 inhibitor reduces muscle soreness, but does not influence recovery and adaptation after eccentric exercise. Scand J Med Sci Sports 2010; 20: e195–207. [PubMed][CrossRef]
- 8.
Paulsen G, Crameri R, Benestad HB et al. Time course of leukocyte accumulation in human muscle after eccentric exercise. Med Sci Sports Exerc 2010; 42: 75–85. [PubMed][CrossRef]
- 9.
Paulsen G, Egner I, Raastad T et al. Inflammatory markers CD11b, CD16, CD66b, CD68, myeloperoxidase and neutrophil elastase in eccentric exercised human skeletal muscles. Histochem Cell Biol 2013; 139: 691–715. [PubMed][CrossRef]
- 10.
Abraham WM. Factors in delayed muscle soreness. Med Sci Sports 1977; 9: 11–20. [PubMed]
- 11.
O'Connor PJ, Cook DB. Exercise and pain: the neurobiology, measurement, and laboratory study of pain in relation to exercise in humans. Exerc Sport Sci Rev 1999; 27: 119–66. [PubMed]
- 12.
Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004; 140: 441–51. [PubMed][CrossRef]
- 13.
Graven-Nielsen T, Mense S, Arendt-Nielsen L. Painful and non-painful pressure sensations from human skeletal muscle. Exp Brain Res 2004; 159: 273–83. [PubMed][CrossRef]
- 14.
Graven-Nielsen T, Arendt-Nielsen L. Assessment of mechanisms in localized and widespread musculoskeletal pain. Nat Rev Rheumatol 2010; 6: 599–606. [PubMed][CrossRef]
- 15.
Dupuy O, Douzi W, Theurot D et al. An evidence-based approach for choosing post-exercise recovery techniques to reduce markers of muscle damage, soreness, fatigue, and inflammation: A systematic review with meta-analysis. Front Physiol 2018; 9: 403. [PubMed][CrossRef]
- 16.
Mackey AL, Mikkelsen UR, Magnusson SP et al. Rehabilitation of muscle after injury - the role of anti-inflammatory drugs. Scand J Med Sci Sports 2012; 22: e8–14. [PubMed][CrossRef]
- 17.
Broatch JR, Petersen A, Bishop DJ. The influence of post-exercise cold-water immersion on adaptive responses to exercise: A review of the literature. Sports Med 2018; 48: 1369–87. [PubMed][CrossRef]
- 18.
Aalborg C, Rød-Larsen C, Leiro I et al. Økning i antall pasienter med treningsindusert rabdomyolyse? Tidsskr Nor Legeforen 2016; 136: 1532–6. [PubMed][CrossRef]
- 19.
Fardal H, Gøransson LG. Treningsutløst rabdomyolyse – en ny tendens? Tidsskr Nor Legeforen 2016; 136: 1537–41. [PubMed][CrossRef]
- 20.
Tazmini K, Schreiner C, Bruserud S et al. Exercise-induced rhabdomyolysis - a patient series. Tidsskr Nor Legeforen 2017; 137. doi: 10.4045/tidsskr.16.1103. [PubMed][CrossRef]
- 21.
Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians. Crit Care 2005; 9: 158–69. [PubMed][CrossRef]
- 22.
Vangstad M, Bjornaas MA, Jacobsen D. Rhabdomyolysis: a 10-year retrospective study of patients treated in a medical department. Eur J Emerg Med 2019; 26: 199–204. [PubMed][CrossRef]
- 23.
Zimmerman JL, Shen MC. Rhabdomyolysis. Chest 2013; 144: 1058–65. [PubMed][CrossRef]
- 24.
Scalco RS, Snoeck M, Quinlivan R et al. Exertional rhabdomyolysis: physiological response or manifestation of an underlying myopathy? BMJ Open Sport Exerc Med 2016; 2: e000151. [PubMed][CrossRef]
- 25.
Rawson ES, Clarkson PM, Tarnopolsky MA. Perspectives on exertional rhabdomyolysis. Sports Med 2017; 47 (suppl 1): 33–49. [PubMed][CrossRef]
- 26.
Flann KL, LaStayo PC, McClain DA et al. Muscle damage and muscle remodeling: no pain, no gain? J Exp Biol 2011; 214: 674–9. [PubMed][CrossRef]
- 27.
Apeland T, Danielsen T, Staal EM et al. Risk factors for exertional rhabdomyolysis with renal stress. BMJ Open Sport Exerc Med 2017; 3: e000241. [PubMed][CrossRef]
- 28.
Clarkson PM, Kearns AK, Rouzier P et al. Serum creatine kinase levels and renal function measures in exertional muscle damage. Med Sci Sports Exerc 2006; 38: 623–7. [PubMed][CrossRef]
- 29.
Jones DA, Newham DJ, Round JM et al. Experimental human muscle damage: morphological changes in relation to other indices of damage. J Physiol 1986; 375: 435–48. [PubMed][CrossRef]
- 30.
Round JM, Jones DA, Cambridge G. Cellular infiltrates in human skeletal muscle: exercise induced damage as a model for inflammatory muscle disease? J Neurol Sci 1987; 82: 1–11. [PubMed][CrossRef]
- 31.
Sayers SP, Clarkson PM, Rouzier PA et al. Adverse events associated with eccentric exercise protocols: six case studies. Med Sci Sports Exerc 1999; 31: 1697–702. [PubMed][CrossRef]
- 32.
Warren JD, Blumbergs PC, Thompson PD. Rhabdomyolysis: a review. Muscle Nerve 2002; 25: 332–47. [PubMed][CrossRef]
()
File
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.